Biodegradable polymeric nanoparticles as drug delivery devices.
暂无分享,去创建一个
A. R. Kulkarni | T. Aminabhavi | K. Soppimath | W. Rudzinski | K S Soppimath | T M Aminabhavi | A R Kulkarni | W E Rudzinski | Walter E. Rudzinski | Tejraj M. Aminabhavi
[1] J. Benoit,et al. End-chain radiolabeling and in vitro stability studies of radiolabeled poly(hydroxy acid) nanoparticles. , 1994, Journal of pharmaceutical sciences.
[2] G. Cavallaro,et al. Pefloxacine mesilate- and ofloxacin-loaded polyethylcyanoacrylate nanoparticles: characterization of the colloidal drug carrier formulation. , 1995, Journal of pharmaceutical sciences.
[3] R. Gurny,et al. Preparation of aqueous polymeric nanodispersions by a reversible salting-out process : influence of process parameters on particle size , 1992 .
[4] J. U. Park,et al. Simple preparation of nanoparticles coated with carbohydrate-carrying polymers. , 1997, Biomaterials.
[5] H. Fessi,et al. Primaquine-loaded poly(lactide) nanoparticles : physicochemical study and acute tolerance in mice , 1995 .
[6] M. Radwan. In Vitro Evaluation of Polyisobutylcyanoacrylate Nanoparticles as a Controlled Drug Carrier for Theophylline , 1995 .
[7] J. Kreuter,et al. Modification of the body distribution of poly(methyl methacrylate) nanoparticles in rats by coating with surfactants , 1990 .
[8] M. Groves,et al. Formulation and Biological Activity of Antineoplastic Proteoglycans Derived from Mycobacterium vaccae in Chitosan Nanoparticles , 1999, The Journal of pharmacy and pharmacology.
[9] H Fessi,et al. Influence of the stabilizer coating layer on the purification and freeze-drying of poly(D,L-lactic acid) nanoparticles prepared by an emulsion-diffusion technique. , 1998, Journal of microencapsulation.
[10] D. Ranney. Biomimetic transport and rational drug delivery. , 2000, Biochemical pharmacology.
[11] J. Poupaert,et al. Development of poly (dialkyl methylidenemalonate) nanoparticles as drug carriers , 1993 .
[12] T. Kissel,et al. Sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide)s facilitate the preparation of small negatively charged biodegradable nanospheres. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[13] S. Davis,et al. The organ uptake of intravenously administered colloidal particles can be altered using a non‐ionic surfactant (Poloxamer 338) , 1984, FEBS letters.
[14] P. Couvreur,et al. [Perspective on the use of microdisperse forms as intracellular vehicles]. , 1978, Pharmaceutica acta Helvetiae.
[15] K. Johnston,et al. Microencapsulation of proteins by rapid expansion of supercritical solution with a nonsolvent , 2000 .
[16] P Couvreur,et al. Adsorption of antineoplastic drugs to polyalkylcyanoacrylate nanoparticles and their release in calf serum. , 1979, Journal of pharmaceutical sciences.
[17] R. Müller,et al. The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. , 1995, Advanced drug delivery reviews.
[18] R. Müller,et al. The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block copolymer--poloxamine 908. , 1987, Life sciences.
[19] F. Leonard. CHAPTER 11 – HEMOSTATIC APPLICATIONS OF ALPHA CYANOACRYLATES: BONDING MECHANISM AND PHYSIOLOGICAL DEGRADATION OF BONDS , 1970 .
[20] Lisa Brannon-Peppas,et al. Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery , 1995 .
[21] Jean W. Tom,et al. Formation of Bioerodible Polymeric Microspheres and Microparticles by Rapid Expansion of Supercritical Solutions , 1991, Biotechnology progress.
[22] Young Moo Lee,et al. Poly(ethylene oxide)–poly(propylene oxide)–poly(ethylene oxide) (Pluronic)/poly(ε-caprolactone) (PCL) amphiphilic block copolymeric nanospheres: I. Preparation and characterization , 1999 .
[23] P Couvreur,et al. Visualization of in vitro protein-rejecting properties of PEGylated stealth polycyanoacrylate nanoparticles. , 1999, Biomaterials.
[24] M. Lück,et al. Plasma protein adsorption on biodegradable microspheres consisting of poly(D,L-lactide-co-glycolide), poly(L-lactide) or ABA triblock copolymers containing poly(oxyethylene). Influence of production method and polymer composition. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[25] Y. M. Lee,et al. Preparation and characterization of biodegradable nanospheres composed of methoxy poly(ethylene glycol) and DL-lactide block copolymer as novel drug carriers. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[26] D. Bazile,et al. Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system. , 1995, Journal of pharmaceutical sciences.
[27] L. Brannon-Peppas,et al. Controlled release of beta-estradiol from PLAGA microparticles: the effect of organic phase solvent on encapsulation and release. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[28] V. Calhoun,et al. Controlled release of bioactive materials. , 1980 .
[29] A. Maruyama,et al. Nanoparticle DNA carrier with poly(L-lysine) grafted polysaccharide copolymer and poly(D,L-lactic acid). , 1997, Bioconjugate chemistry.
[30] P Couvreur,et al. Complement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly(isobutyl 2-cyanoacrylate) nanoparticles. , 1997, Life sciences.
[31] E. Mathiowitz,et al. Nanosphere based oral insulin delivery. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[32] C Vigneron,et al. Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[33] F. Veronese,et al. Stabilization of substances in circulation. , 1998, Bioconjugate chemistry.
[34] Yoshiaki,et al. Preparations of biodegradable nanospheres of water-soluble and insoluble drugs with D, L-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behavior. , 1993 .
[35] Andreas Zimmer,et al. Microspheres and nanoparticles used in ocular delivery systems , 1995 .
[36] M. Alonso,et al. Approaches to improve the association of amikacin sulphate to poly(alkylcyanoacrylate) nanoparticles , 1991 .
[37] A. Schindler,et al. Sustained drug delivery systems II: Factors affecting release rates from poly(epsilon-caprolactone) and related biodegradable polyesters. , 1979, Journal of pharmaceutical sciences.
[38] N. Wang,et al. A novel biodegradable system based on gelatin nanoparticles and poly(lactic-co-glycolic acid) microspheres for protein and peptide drug delivery. , 1997, Journal of pharmaceutical sciences.
[39] G. Gregoriadis. Drug carriers in biology and medicine , 1979 .
[40] P. Couvreur,et al. Development of sterically stabilized poly(isobutyl 2-cyanoacrylate) nanoparticles by chemical coupling of poly(ethylene glycol). , 1997, Journal of biomedical materials research.
[41] Tae Gwan Park,et al. Preparation of porous and nonporous biodegradable polymeric hollow microspheres , 1995 .
[42] R. Manly. Adhesion in biological systems. , 1967, Science.
[43] S. Benita,et al. A new in vitro technique for the evaluation of drug release profile from colloidal carriers - ultrafiltration technique at low pressure , 1993 .
[44] T Görner,et al. Lidocaine loaded biodegradable nanospheres. II. Modelling of drug release. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[45] V. Torchilin,et al. Biodegradable long-circulating polymeric nanospheres. , 1994, Science.
[46] T. Uchida,et al. Instability of bovine insulin in poly(lactide-co-glycolide) (PLGA) microspheres. , 1996, Chemical & pharmaceutical bulletin.
[47] R. Müller,et al. Surface modification of i.v. injectable biodegradable nanoparticles with poloxamer polymers and poloxamine 908 , 1993 .
[48] Rainer H. Müller,et al. Alkylcyanoacrylate drug carriers: II. Cytotoxicity of cyanoacrylate nanoparticles with different alkyl chain length , 1992 .
[49] M. Boroujerdi,et al. Investigation of the relative affinity of doxorubicin for neutral and negatively charged particulate carriers , 1993 .
[50] P. Couvreur,et al. Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[51] R. Müller,et al. Adsorption of ethoxylated surfactants on nanoparticles. I. Characterization by hydrophobic interaction chromatography , 1991 .
[52] Simon Benita,et al. The influence of process parameters on the PLA nanoparticle size distribution, evaluated by means of factorial design , 1995 .
[53] D. A. Kharkevich,et al. Analgesic activity of the hexapeptide dalargin adsorbed on the surface of polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles , 1995 .
[54] Robert Langer,et al. PEG-coated nanospheres from amphiphilic diblock and multiblock copolymers: Investigation of their drug encapsulation and release characteristics1 , 1997 .
[55] Lu Ze,et al. A method for the preparation of polymeric nanocapsules without stabilizer. , 1999 .
[56] J. Kreuter,et al. Colloidal Drug Delivery Systems , 1994 .
[57] D. Bazile,et al. Effect of PEO surface density on long-circulating PLA-PEO nanoparticles which are very low complement activators. , 1996, Biomaterials.
[58] D. Begley,et al. Saturable mechanism for delta sleep-inducing peptide (DSIP) at the blood-brain barrier of the vascularly perfused guinea pig brain , 1989, Peptides.
[59] J. Poupaert,et al. Poly(diethyl methylidenemalonate) nanoparticles as a potential drug carrier: preparation, distribution and elimination after intravenous and peroral administration to mice. , 1991, Journal of pharmaceutical sciences.
[60] M. Alonso,et al. Novel hydrophilic chitosan‐polyethylene oxide nanoparticles as protein carriers , 1997 .
[61] M A Egea,et al. Entrapment of cisplatin into biodegradable polyalkylcyanoacrylate nanoparticles. , 1994, Farmaco.
[62] R. Gurny,et al. New approach for the preparation of nanoparticles by an emulsification-diffusion method , 1995 .
[63] V. Torchilin. Polymer-coated long-circulating microparticulate pharmaceuticals. , 1998, Journal of microencapsulation.
[64] C. J. Oss,et al. Phagocytosis as a Surface Phenomenon , 1978 .
[65] S. Kagatani,et al. Nanosphere Coated with Lactosyl-Polystyrene Polymer as a Targeting Carrier to Hepatocytes , 1999 .
[66] S. Davis,et al. Effect of the nonionic surfactant poloxamer 338 on the fate and deposition of polystyrene microspheres following intravenous administration. , 1983, Journal of pharmaceutical sciences.
[67] Patrick Couvreur,et al. Controlled drug delivery with nanoparticles : current possibilities and future trends , 1995 .
[68] P. Couvreur,et al. Nano- and microparticles for the delivery of polypeptides and proteins , 1993 .
[69] G. Cavallaro,et al. Entrapment of β-lactams antibiotics in polyethylcyanoacrylate nanoparticles: Studies on the possible in vivo application of this colloidal delivery system , 1994 .
[70] C Washington,et al. Drug release from microdisperse systems: a critical review , 1990 .
[71] R. Arshady. Preparation of biodegradable microspheres and microcapsules: 2. Polyactides and related polyesters , 1991 .
[72] K. Johnston,et al. Formation of poly(1,1,2,2-tetrahydroperfluorodecyl acrylate) submicron fibers and particles from supercritical carbon dioxide solutions , 1995 .
[73] B. Sabel,et al. Nanoparticle technology for delivery of drugs across the blood-brain barrier. , 1998, Journal of pharmaceutical sciences.
[74] M. Alonso,et al. Formulation of L-asparaginase-loaded poly(lactide-co-glycolide) nanoparticles: influence of polymer properties on enzyme loading, activity and in vitro release. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[75] Jean W. Tom,et al. Precipitation of poly(l-lactic acid) and composite poly(l-lactic acid)-pyrene particles by rapid expansion of supercritical solutions , 1994 .
[76] M. Alonso. Nanoparticulate Drug Carrier Technology , 1996 .
[77] D. Wise,et al. POLYLACTIC ACID AS A BIODEGRADABLE CARRIER FOR CONTRACEPTIVE STEROIDS , 1973 .
[78] M. Groves,et al. Gelatin Behaviour in Dilute Aqueous Solution: Designing a Nanoparticulate Formulation , 1999, The Journal of pharmacy and pharmacology.
[79] I. Fishbein,et al. Nanoparticulate delivery system of a tyrphostin for the treatment of restenosis. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[80] R. K. Kulkarni,et al. The degradation of n-butyl alpha-cyanoacrylate tissue adhesive. II. , 1968, Surgery.
[81] R. Jalil,et al. Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties. , 1990, Journal of microencapsulation.
[82] D. Wise,et al. An injectable sustained release fertility control system. , 1976, Contraception.
[83] S. Yeung,et al. Sub‐Micrometer‐Sized Biodegradable Particles of Poly(L‐Lactic Acid) via the Gas Antisolvent Spray Precipitation Process , 1993, Biotechnology progress.
[84] G. Ponchel,et al. Cyclodextrins and carrier systems. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[85] M. El-Samaligy,et al. Polyalkyl cyanoacrylate nanocapsules , 1986, The Journal of pharmacy and pharmacology.
[86] D. Hochstrasser,et al. Kinetics of plasma protein adsorption on model particles for controlled drug delivery and drug targeting , 1996 .
[87] C. G. Knight. Liposomes, from physical structure to therapeutic applications , 1981 .
[88] K. Shakesheff,et al. Polymeric systems for controlled drug release. , 1999, Chemical reviews.
[89] J. Poupaert,et al. Synthesis of C-14-labeled Acrylic Derivatives - Diethyl [3-c-14] Methylidenemalonate and Isobutyl [3-c-14] Cyanoacrylate , 1989 .
[90] M. Ueda,et al. Influence of the preparation methods on the drug release behaviour of loperamide-loaded nanoparticles. , 1998, Journal of microencapsulation.
[91] S. Benita,et al. Nanoparticle characterization : a comprehensive physicochemical approach , 1991 .
[92] R. Müller,et al. In vitro phagocytosis assay of nano- and microparticles by chemiluminescence. III. Uptake of differently sized surface-modified particles, and its correlation to particle properties and in vivo distribution , 1993 .
[93] Robert Gurny,et al. Drug-loaded nanoparticles : preparation methods and drug targeting issues , 1993 .
[94] Bernhard A. Sabel,et al. Nanoparticles, a drug carrier system to pass the blood-brain barrier, permit central analgesic effects of i.v. dalargin injections , 1996, Brain Research.
[95] K. Audus,et al. Uptake of surfactant-coated poly(methyl methacrylate)-nanoparticles by bovine brain microvessel endothelial cell monolayers , 1994 .
[96] H. Takeuchi,et al. Pulmonary delivery of insulin with nebulized DL-lactide/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[97] P. Couvreur,et al. Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties , 1979, The Journal of pharmacy and pharmacology.
[98] Gert Storm,et al. Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system , 1995 .
[99] W. Semmler,et al. The influence of the sample preparation on plasma protein adsorption patterns on polysaccharide-stabilized iron oxide particles and N-terminal microsequencing of unknown proteins. , 1997, Journal of drug targeting.
[100] M. Alonso,et al. Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules, and nanoemulsions, as ocular drug carriers. , 1996, Journal of pharmaceutical sciences.
[101] S. Benita,et al. Drug release from submicronized o/w emulsion: a new in vitro kinetic evaluation model , 1990 .
[102] Joseph D. Andrade,et al. Protein—surface interactions in the presence of polyethylene oxide , 1991 .
[103] B. Sabel,et al. Efficacy of Oral Dalargin-loaded Nanoparticle Delivery across the Blood–Brain Barrier , 1998, Peptides.
[104] R. Langer,et al. Biomaterials in drug delivery and tissue engineering: one laboratory's experience. , 2000, Accounts of chemical research.
[105] P. Couvreur,et al. New Poly(Methylidene Malonate 2.1.2) Nanoparticles: Recent Developments , 1994 .
[106] C. Roques-carmes,et al. Physico-chemical characterization, preparation and performance of poly (methylidene malonate 2.1.2) nanoparticles. , 1998, Biomaterials.
[107] Jean W. Tom,et al. Particle formation with supercritical fluids—a review , 1991 .
[108] T. Gray,et al. A single dose of intravenously injected poloxamine-coated long-circulating particles triggers macrophage clearance of subsequent doses in rats. , 1997, Clinical science.
[109] A. Schindler,et al. Biodegradable drug delivery systems based on aliphatic polyesters: application to contraceptives and narcotic antagonists. , 1981, NIDA research monograph.
[110] D. A. Kharkevich,et al. Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study. , 1998, Journal of microencapsulation.
[111] R. Bodmeier,et al. Solvent selection in the preparation of poly(dl-lactide) microspheres prepared by the solvent evaporation method , 1988 .
[112] K. Audus,et al. In‐vitro Characterization of Blood‐brain Barrier Permeability to Delta Sleep‐inducing Peptide , 1989, The Journal of pharmacy and pharmacology.
[113] L. Balant,et al. Kinetics of blood component adsorption on poly(D,L-lactic acid) nanoparticles: evidence of complement C3 component involvement. , 1997, Journal of biomedical materials research.
[114] A. Coombes,et al. The preparation of sub-200 nm poly(lactide-co-glycolide) microspheres for site-specific drug delivery , 1993 .